A SHR3680 QT/QTc Study on Castration-Resistant Prostate Cancer Subjects
Condition(s):Castration-Resistant Prostate CancerLast Updated:May 15, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Castration-Resistant Prostate CancerLast Updated:May 15, 2023Recruiting
Condition(s):Metastatic Prostate CancerLast Updated:January 24, 2024Active, not recruiting
Condition(s):Prostate CancerLast Updated:September 4, 2020Completed
Condition(s):Prostate CancerLast Updated:January 24, 2019Withdrawn
Condition(s):Castration-resistant Prostate CancerLast Updated:October 19, 2021Completed
Condition(s):Melanoma; Prostate Cancer; Renal CancerLast Updated:March 4, 2022Terminated
Condition(s):Prostatic NeoplasmsLast Updated:January 27, 2016Completed
Condition(s):Castration-resistant Prostate Cancer Patients With OligometastasesLast Updated:October 20, 2020Recruiting
Condition(s):Metastatic Castration-Resistant Prostate CancerLast Updated:March 9, 2020Terminated
Condition(s):Prostate CancerLast Updated:September 25, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.